AMARIN CORPORATION ANNOUNCES ACCEPTANCE FOR FILING OF NEW DRUG APPLICATION FOR ZELAPAR™ BY US FDA - Amarin
Home Site Map Contact Us Graphics Version Printer Version Main Navigation ABOUT US COMPANY PROFILE Recent 2007 2006 2005 2004 2003 2002 2001 2000 STRATEGY Recent 2007 2006 2005 2004 2003 2002 2001 2000 MANAGEMENT TEAM Recent 2007 2006 2005 2004 2003 2002 2001 2000 BOARD OF DIRECTORS Recent 2007 2006 2005 2004 2003 2002 2001 2000 SCIENTIFIC ADVISORY BOARD Recent 2007 2006 2005 2004...
author: Webtrade Ltd. - http://www.webtrade.ie
AMARIN CORPORATION ANNOUNCES ZELAPAR™ RECEIVES APPROVABLE LETTER FROM FDA - Amarin
Home Site Map Contact Us Graphics Version Printer Version Main Navigation ABOUT US COMPANY PROFILE Recent 2007 2006 2005 2004 2003 2002 2001 2000 STRATEGY Recent 2007 2006 2005 2004 2003 2002 2001 2000 MANAGEMENT TEAM Recent 2007 2006 2005 2004 2003 2002 2001 2000 BOARD OF DIRECTORS Recent 2007 2006 2005 2004 2003 2002 2001 2000 SCIENTIFIC ADVISORY BOARD Recent 2007 2006 2005 2004...
author: Webtrade Ltd. - http://www.webtrade.ie
DRAXIS Health Inc.
News Releases - - June 4, 2002 DRAXIS Provides Further Update to Proposed Sale of Canadian Sales and Marketing Division - - MISSISSAUGA, ONTARIO, June 4, 2002 - DRAXIS Health Inc. Under the modified agreement, Elan will acquire Canadian product rights for Zanaflex®, Diastat®, Mysoline®, Permax®, Eldepryl®, Novo-Selegiline, Ziconotide, MYOBLOC,...
http://www.amarincorp.com/documents/form20f2000.pdf page 23
http://www.amarincorp.com/documents/AmarinCorporation20F2001.pdf page 14
FORM 20-F page 23
author: FBOL Reception
Database Z
Z - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- -link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
CW0907_Jul02.qxd page 13
author: Liz
http://www.draxis.com/pdf/fact_sheet.pdf
1998 1999 2000 TODAY'S PRODUCTS TOMORROW'S PRODUCTS Status Product Indication Country sold Product Indication Pre- clin Ph I Ph II Ph III Filed Market DRAXIMAGE Sodium iodide Thyroid disorders Canada/ Export BrachySeed ª Prostate cancer therapeutic ue ue ue ue ue Iodohippurate Renal plasma flow Canada Fibrimage ® Deep vein thrombosis ue ue ue ue Cyanocobalamine Diagnosis of...
http://www.draxis.com/pdf/fact_sheet.pdf page 4
http://www.draxis.com/pdf/draxis_1999.pdf
Martin Barkin (Signed) President, Chief Executive Officer and Chief Operating Officer April 30, 2000 Today's Products: DRAXIMAGE DRAXIS Pharmaceutica Companion Animal Health Unique Pharmaceuticals for Product Indication Country sold Sodium iodide Thyroid disorders Canada/ Export Iodohippurate Renal plasma flow Canada Cyanocobalamine Diagnosis of vitamin B 12 absorption Canada/ Export...
http://www.draxis.com/pdf/draxis_2000.pdf
DRAXIS HEALTH INC revenues increase from under $900 million in 1999 to $1.6 billion by 2006 1 5 Product Indication Pre- clinical Ph I Ph II Ph III Filed Ziconotide Severe pain ue ue ue ue ue MYOBLOC ª Cervical dystonia ue ue ue ue ue Frovelan Migraine ue ue ue ue ue Hectorol ª Secondary hyperparathyroidism ue ue ue ue ue Levulan ® PDT Actinic Keratoses ue ue ue...
01-299 NewMedNeuroDis for PDF page 13
author: RL
http://www.athenaneuro.com/Images/2_1755.pdf page 12
Neurobloc: Botulinum toxin is a potent neurotoxin, best known as the cause of the potentially fatal form of bacterial food poisoning called botulism. Scientists have found that this toxin can be formulated into useful pharmaceutical agents. Neurobloc, Elan's formulation of botulinum toxin type ...
Database E
E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Database S
S - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products. See TOCOSOL Camptothecin (3313) S-9156 (1729) S-3APG, See ENMD 0995 (2814) SA-IVIG (Staphylococcus Aureus-Hyperimmune Intravenous...
http://www.fda.gov/cder/orange/appendix_a.txt
2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
KG "SELEGILINE HYDROCHLORIDE MANUFACTURED IN MINDEN, FEDERAL REPUBLIC OF GERMANY" 10349 12-Jul-93 BURZYNSKI RESEARCH INSTITUTE INC "ANTINEOPLASTON AS2-1 INJECTIONS MANUFACTURED IN STAFFORD, TEXAS" 10350 23-Jun-93 STAROGARD PHARMACEUTICAL WORKS "TINIDAZOLE MANUFACTURED IN STAROGARD GDANSKI, POLAND" 10353 13-Jul-93 BAYER AG "CIPROFLOXACIN ORAL NEW DRUG SUBSTANCE...
ANDA Approvals - September 2003
9/12/2003- 18 75-145 SELEGILINE HYDROCHLORIDE CAPSULES 5 MG - AAI PHARMA 9/15/2003- 19 75-763 NEFAZODONE HYDROCHLORIDE TABLETS 50 MG, 100 MG, 150 MG, 200 MG, AND 250 MG - IVAX PHARMACEUTICALS, INC 9/16/2003- 21 76-409 NEFAZODONE HYDROCHLORIDE TABLETS 50 MG, 100 MG, 150 MG, 200 MG, AND 250 MG - RANBAXY LABORATORIES LIMITED 9/16/2003- 22 76-037 NEFAZODONE ...
Prescription and Over-the-Counter Drug Product List: 9/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> + MIKART 325MG/15ML;7.5MG/15ML N40482 001 SEP 25, 2003 SEP NEWA ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET; ORAL >A> OXYCODONE AND ACETAMINOPHEN >A> AA WATSON LABS 325MG;7.5MG N40535 001 SEP 05, 2003 SEP NEWA >A> AA 325MG...
author: AUTHOR
1997 Abbreviated New Drug Applications (Generic Drugs)
074946 11/19/1997 3/30/1998 Adriamycin PFS (Doxorubicin Hydrochloride) Injection ,- Adria Laboratories 63165/S3, S5, S6 7/9/1993 8/8/2002 Albuterol Inhalation Aerolsol, 90 mcg/Actuation 64136 9/30/96 4/13/99 Clomipramine Hydrochloride [2 MB] Taro Pharmaceuticals 074694 12/13/1996 12/3/1997 Clomipramine Hydrochloride Capsules, 25, 50, & 75 mg 74-648 3/18/97 4/8...
Prescription and OTC Drug Product List 8/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE -A- AA ABLE 300MG;30MG N40452 001 AUG 01, 2002 AUG NEWA -A- AA 300MG;60MG N40459 001 AUG 01, 2002 AUG NEWA ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE TABLET; ORAL ACETAMINOPHEN AND PENTAZOCINE HCL -A- AB AMIDE PHARM 650MG;EQ 25MG BASE N76202 001...
Prescription and OTC Drug Product List 6/2002
-D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
Prescription and OTC Drug Product List 4/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL ACETAMINOPHEN, BUTALBITAL, CAFFEINE, AND CODEINE PHOSPHATE -A- AB VINTAGE PHARMS 325MG;50MG;40MG;30MG N75929 001 APR 22, 2002 APR NEWA ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE;...
Export Products List by System July 2003 page 42
author: Lee S. Ehler